RayStation has been chosen as the primary treatment planning system through a tender process, replacing the current treatment planning systems at the Centre intégré universitaire de santé et de services sociaux de l'Estrie-Centre hospitalier universitaire de Sherbrooke, in Quebec, Canada. The center treats approximately 2000 cancer patients a year and is equipped with 4 linear accelerators.
RayStation was selected as the primary treatment planning system replacing their current system. The decision was motivated by RayStation’s outstanding functionality, such as scripting, multi-criteria optimization, streamlined adaptive therapy and automation. The purchase contains of a wide array of modules including multi-criteria optimization, Plan Explorer, AutoBreast planning and full support for adaptive radiotherapy. The full installation supports approximately 20 simultaneous users.
Charles Lavoie, Coordinator of the Medical Physics group, says: “We are pleased that, through the tender process, we have found a treatment planning system that will satisfy our needs. RayStation will provide all of the latest technologies, and in addition help our department to be efficient. We look forward to implementing this system clinically.”
Johan Löf, CEO of RaySearch, says: “We are pleased to have won another important tender with RayStation in Canada, and satisfied to have been able to meet all demands from the highly recognized clinic, Centre intégré universitaire de santé et de services sociaux de l'Estrie-Centre hospitalier universitaire de Sherbrooke. We look forward to see how our collaboration will evolve.”
The majority of this order has been delivered and will generate revenue in the second quarter of 2018.
About Centre intégré universitaire de santé et de services sociaux de l'Estrie-Centre hospitalier universitaire de Sherbrooke
The center is treating approximately 2000 patients a year and counts more than 17,000 employees including more than 1,000 physicians. It serves a territory spreading from Lac-Mégantic to Ange-Gardien comprising a population of more than 500,000 inhabitants.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59